Literature DB >> 3000583

Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.

L J Murphy, R L Sutherland, B Stead, L C Murphy, L Lazarus.   

Abstract

Epidermal growth factor (EGF) receptors are present in human breast cancer and probably mediate the effects of EGF and the autocrine effects of alpha-transforming growth factors, produced by breast cancer cells. Steroid hormones influence the growth of some human cancers, and both direct and indirect effects on cell proliferation have been proposed. One potential indirect effect of steroids would be to augment sensitivity to other endocrine and autocrine factors by up-regulation of their receptors. We therefore investigated the effects of various steroids on EGF receptor expression in T-47D, MCF-7, and BT 20 human mammary carcinoma cells in culture. Preincubation of T-47D cells for 24 h with a series of androgens, estrogens, glucocorticoids, and progestins resulted in a significant enhancement of specific 125I-EGF binding in the presence of progestins only. Increased binding of EGF was associated with neither a change in cell number nor changes in the specific binding of concanavalin A, insulin, or calcitonin but was accompanied by an increase in lactogenic receptor expression. When assayed at 20 degrees C, increased EGF binding was due to an increase in receptor number (33,380 +/- 7,410 sites/cell in control cultures; 67,460 +/- 20,330 sites/cell in cultures treated with 1 nM medroxyprogesterone acetate for 24 h; P less than 0.05) without a change in receptor affinity. Two- to 3-fold increases in receptor number were also apparent when binding was measured at 4 degrees C, indicating that the effect was due to an increase in expression of receptor at the cell surface rather than progestin effects on internalization and degradation. These data illustrate that the expression of EGF receptor in some breast cancer cells is regulated in part by mechanisms mediated via the progesterone receptor, since the effect was confined to progestins, potency among a series of progestins was correlated with their affinities for progesterone receptor, and sensitivity among the three cell lines studied was related to the presence and concentration of cellular progesterone receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3000583

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF.

Authors:  P G Gill; W D Tilley; N J De Young; I L Lensink; P D Dixon; D J Horsfall
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872

2.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.

Authors:  E A Musgrove; C S Lee; R L Sutherland
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

Review 3.  Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin.

Authors:  Guillermo P Vicent; A Silvina Nacht; Roser Zaurín; Cecilia Ballaré; Jaime Clausell; Miguel Beato
Journal:  Mol Endocrinol       Date:  2010-05-19

4.  Serum-free culture of enriched mouse anterior and ventral prostatic epithelial cells in collagen gel.

Authors:  T Turner; H A Bern; P Young; G R Cunha
Journal:  In Vitro Cell Dev Biol       Date:  1990-07

5.  Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle.

Authors:  A Gompel; A Martin; P Simon; D Schoevaert; G Plu-Bureau; D Hugol; J Audouin; E Leygue; J B Truc; P Poitout
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 6.  Hormonal regulation of type I receptor tyrosine kinase expression in the mammary gland.

Authors:  M De Bortoli; C Dati
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

7.  Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin.

Authors:  R Poulin; J M Dufour; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

8.  Progestin treatment depresses estrogen receptor but not cathepsin D levels in needle aspirates of benign breast disease.

Authors:  T Maudelonde; P Lavaud; G Salazar; F Laffargue; H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1991-10       Impact factor: 4.872

9.  Role of transforming growth factor-alpha-related peptides in the autocrine/paracrine control of experimental breast cancer growth in vitro by estradiol, prolactin, and progesterone.

Authors:  A Manni; C Wright; B Badger; M Bartholomew; M Herlyn; J Mendelsohn; H Masui; L Demers
Journal:  Breast Cancer Res Treat       Date:  1990-02       Impact factor: 4.872

10.  Characterization of normal breast epithelial cells in primary cultures: differentiation and growth factor receptors studies.

Authors:  P Berthon; G Pancino; P de Cremoux; A Roseto; C Gespach; F Calvo
Journal:  In Vitro Cell Dev Biol       Date:  1992 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.